AU Patent

AU2018222983B2 — Ultra Low Density Pulmonary Powders

Assigned to Merz Pharmaceuticals LLC · Expires 2020-02-27 · 6y expired

What this patent protects

The invention provided pharmaceutical compositions for pulmonary delivery comprising particles containing a pharmaceutical agent and having a geometric size of greater than about 5 pm and a tap density of less than about 0.075 g/cm3. The invention also provides methods for deli…

USPTO Abstract

The invention provided pharmaceutical compositions for pulmonary delivery comprising particles containing a pharmaceutical agent and having a geometric size of greater than about 5 pm and a tap density of less than about 0.075 g/cm3. The invention also provides methods for delivering the pharmaceutical compositions of the invention to the respiratory tract of a patient.

Drugs covered by this patent

Patent Metadata

Patent number
AU2018222983B2
Jurisdiction
AU
Classification
—
Expires
2020-02-27
Drug substance claim
No
Drug product claim
No
Assignee
Merz Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.